The Patent Finder

Transgene

3 patents currently held · Updated Nov 21, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Previously recorded as Transgene S.A. (to 2025)

0
Ending by 2030
Feb 2036
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Oct 30, 2027
    The maintenance fee for Personalized Vaccine (US 11,969,462) comes due Oct 30, 2027. Unpaid by May 1, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Showing 1 to 3 of 3

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 12,544,415Immunotherapeutic Vaccine and Antibody Combination Therapy
In force
 · Medium confidence
In forceMedium confidence
US 11,969,462Personalized Vaccine
In force
 · High confidence
In forceHigh confidence
US 12,377,142Recombinant pseudocowpoxvirus
In force
 · USPTO record
In forceUSPTO record
Also on record, not counted in the 3: 1 lapsed for an unpaid fee · 2 ended at full term. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

3 pending · 1 abandoned · 2 no status recorded

Showing 1 to 6 of 6, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page. Where no title is shown, the bulk publication record carries none and this site holds no USPTO file history for that application.

ApplicationTitleFiledStatus
18/299,858Personalized VaccineApr 13, 2023Pending
18/015,820Jul 13, 2021No status recorded
17/787,980Process for Designing a Recombinant Poxvirus for a Therapeutic VaccineDec 22, 2020Pending
17/418,426M2-DEFECTIVE PoxvirusDec 27, 2019Pending
17/413,228Production of Viral Vaccines on an Avian Cell LineDec 12, 2019Abandoned
09/935,423Aug 23, 2001No status recorded
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited